The Annals rips a commercially-sponsored study a new one

April 8, 2007

The trial showed the benefits of the diabetes drug Byetta. The accompanying editorial is not kind.



Related posts:

  1. Avandia: The RECORD study
  2. Does Avandia cause heart attacks, and why the RECORD study is important
  3. Flaws in the Avandia study?
  4. Does insulin cause cancer, and should you stop taking Lantus?
  5. The $130 million study that no one listened to
  6. Are Actos and Avandia to blame for rising diabetes costs?
  7. Medblogs in the Annals of Emergency Medicine


KevinMD.com on Facebook


  Follow on Twitter   Subscribe



Tagged as: diabetes

Comments on this entry are closed.

Previous post: CNN dismisses the ACP on breast cancer screening

Next post: Statistics for journalists

Site Meter